Abstracts 5th World Congress 2005
Editorial
Contents
Plenary Lectures (5-7)
Theme 1: Education
Session 1.1: Refinement and reduction alternatives in education (8-13)
Session 1.2: Replacement alternatives in education (14-22)
Workshop 1.3: Educating the scientist in animal alternatives (23-33)
Workshop 1.4: Multi-media exhibits of alternatives in education (34-36)
Theme 2: Laboratory animal welfare and refinement
Workshop 2.1: Environmental enrichment and housing standards (37-41)
Session 2.2: Pain, welfare and analgesia (42-51)
Session 2.3: Non-invasive approaches - new imaging and remote techniques (52-57)
Session 2.4: Non-human primates-housing, enrichment, positive reinforcement training (58-61)
Session 2.5: Specific animal models and refinement (62-72)
Workshop 2.6: Humane endpoints (73-74)
Theme 3: Moral issues of animals, alternatives and public policy
Session 3.1: Influencing and making public policy (75-83)
Workshop 3.2: Establishing the 3Rs principle around the world (84-89)
Workshop 3.3: Forum of national and international institutions funding (90-94)
Session 3.4: Policy implementation (95-98)
Session 3.5: Ethical review - good practice and outputs (99-104)
Workshop 3.6: Establishing the 3Rs principle in Japan (JSAAE-Workshop) (105-108)
Theme 4: Information systems and databases
Session 4.1: 3Rs Databases and services - development worldwide (109-113)
Session 4.2: Information retrieval - search strategies (114-116)
Workshop 4.3: Search strategies - user requirements (117-118)
Theme 5: Safety testing, validation and risk assessment
Session 5.1: Strategies for using non-animal methods in relation to HPV, endocrine disruptors, and REACH legislation (119-127)
Session 5.2: New approaches to risk assessment (ESTIV-Symposion) (128-136)
Session 5.3: Progress and needs for developing and validating alternatives for dermal toxicity testing (137-149)
Session 5.4: Development and validation of alternatives for dermal toxicity testing (150-168)
Session 5.5: Advancements and needs for developing and validating alternatives for ocular irritancy and corrosivity testing (169-182)
Session 5.6: In vitro approaches for determining acute systemic toxicity (183-199)
Session 5.7: Progress in quality assurance for in vitro alternative studies (200-206)
Session 5.8: Challenges in food toxicity testing (207-211)
Session 5.9: Biologicals: Progress and new approaches (212-224)
Workshop 5.10: Ecotoxicity - applying the Three Rs (225-232)
Workshop 5.11: Mechanisms of chemically-induced ocular injury and recovery: Current understanding and research needs (233-241)
Workshop 5.12: Toxicogenomics - potential, validation, and case studies (242-248)
Workshop 5.13: Strategies for prioritising and streamlining the validation process (249-253)
Workshop 5.14: Meeting the challenge of the 7th Amendment to the EU Cosmetics Directive (254-260)
Workshop 5.15: In vitro metabolism: Applications in pharmacology and toxicology (261-264)
Workshop 5.16: Reproductive toxicology - the EU ReProTect project (265-268)
Theme 6: Modelling
Session 6.1: QSAR acceptance and implementation (269-274)
Session 6.2: Biokinetic modelling in silico (275-277)
Session 6.3: Computational toxicology (278-286)
Theme 7: Applying new science and technology
Session 7.1: Stem cell technology (287-296)
Session 7.2: Innovative approaches for alternative methods development (297-311)
Session 7.3: The contribution of the OMICS technology to the 3Rs (312-317)
Session 7.4: Non-invasive techniques for monitoring and imaging (318-323)
Session 7.5: Novel cell culture techniques (324-340)
Session 7.6: Non-genotoxic carcinogenicity: Mechanistic perspectives for alternatives (341-348)
Authors